annual working capital:
$302.21M+$61.95M(+25.79%)Summary
- As of today (August 1, 2025), ELVN annual working capital is $302.21 million, with the most recent change of +$61.95 million (+25.79%) on December 31, 2024.
- During the last 3 years, ELVN annual working capital has risen by +$197.29 million (+188.05%).
- ELVN annual working capital is now at all-time high.
Performance
ELVN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$280.35M-$21.87M(-7.24%)Summary
- As of today (August 1, 2025), ELVN quarterly working capital is $280.35 million, with the most recent change of -$21.87 million (-7.24%) on March 31, 2025.
- Over the past year, ELVN quarterly working capital has dropped by -$31.82 million (-10.19%).
- ELVN quarterly working capital is now -10.19% below its all-time high of $312.17 million, reached on March 31, 2024.
Performance
ELVN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
ELVN Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.8% | -10.2% |
| 3 y3 years | +188.1% | - |
| 5 y5 years | +134.1% | +167.2% |
ELVN Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +344.2% | -10.2% | +312.0% |
| 5 y | 5-year | at high | +344.2% | -10.2% | +312.0% |
| alltime | all time | at high | +344.2% | -10.2% | +312.0% |
ELVN Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $280.35M(-7.2%) |
| Dec 2024 | $302.21M(+25.8%) | $302.21M(+7.9%) |
| Sep 2024 | - | $279.97M(-5.4%) |
| Jun 2024 | - | $296.02M(-5.2%) |
| Mar 2024 | - | $312.17M(+29.9%) |
| Dec 2023 | $240.26M | $240.26M(-6.3%) |
| Sep 2023 | - | $256.53M(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $274.03M(-4.5%) |
| Mar 2023 | - | $287.06M(+321.9%) |
| Dec 2022 | $68.04M(-35.2%) | $68.04M(-14.8%) |
| Sep 2022 | - | $79.90M(-23.8%) |
| Dec 2021 | $104.92M(-18.7%) | - |
| Dec 2021 | - | $104.92M |
| Dec 2020 | $129.11M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual working capital?
- What is the all time high annual working capital for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual working capital year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly working capital?
- What is the all time high quarterly working capital for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly working capital year-on-year change?
What is Enliven Therapeutics, Inc. annual working capital?
The current annual working capital of ELVN is $302.21M
What is the all time high annual working capital for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual working capital is $302.21M
What is Enliven Therapeutics, Inc. annual working capital year-on-year change?
Over the past year, ELVN annual working capital has changed by +$61.95M (+25.79%)
What is Enliven Therapeutics, Inc. quarterly working capital?
The current quarterly working capital of ELVN is $280.35M
What is the all time high quarterly working capital for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly working capital is $312.17M
What is Enliven Therapeutics, Inc. quarterly working capital year-on-year change?
Over the past year, ELVN quarterly working capital has changed by -$31.82M (-10.19%)